{"id":272843,"date":"2026-09-10T09:42:17","date_gmt":"2026-09-10T09:42:17","guid":{"rendered":"https:\/\/www.europesays.com\/ee\/272843\/"},"modified":"2026-09-10T09:42:17","modified_gmt":"2026-09-10T09:42:17","slug":"endine-konkurent-suudistab-serena-williamsit-kui-need-ravimid-on-ohtlikud-toetan-eluaegset-voistluskeeldu","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ee\/272843\/","title":{"rendered":"Endine konkurent s\u00fc\u00fcdistab Serena Williamsit: kui need ravimid on ohtlikud, toetan eluaegset v\u00f5istluskeeldu"},"content":{"rendered":"<p>32-aastane Bouchard, kes hoidis karj\u00e4\u00e4ri parimal p\u00e4eval maailma edetabelis viiendat kohta, t\u00f5i intervjuus v\u00e4ljaandele Front Office Sports v\u00e4lja, et Williamsi tipptennisesse tagasitulek sai v\u00f5imalikuks vaid t\u00e4nu GLP-1 ravimitele. Tegemist on ravimitega, mis v\u00e4hendavad s\u00f6\u00f6giisu, aeglustavad mao t\u00fchjenemist ja aitavad langetada veresuhkrut ning kehakaalu. T\u00e4nu neile ravimitele kaotas Williams p\u00e4rast oma teise lapse s\u00fcndi 14 kilo.<\/p>\n<p>Kuigi GLP-1 ravimid ei ole Maailma Antidopingu Agentuuri (<a rel=\"noopener nofollow\" target=\"_blank\" href=\"https:\/\/www.delfi.ee\/teema\/56939692\/wada\" tag-id=\"56939692\">WADA<\/a>) keelatud ainete nimekirjas, ei peeta nende tarbimist spordis \u00f5igeks. Usutakse, et ravimid v\u00f5ivad tekitada k\u00f5rvalm\u00f5judena s\u00f6\u00f6mish\u00e4ireid ja need m\u00f5jutavad ka vaimset tervist.<\/p>\n<p>Bouchari s\u00f5nul on <a rel=\"noopener nofollow\" target=\"_blank\" href=\"https:\/\/www.delfi.ee\/teema\/96862916\/doping-1\" tag-id=\"96862916\">dopingu<\/a> kasutamine tennises t\u00f5sine probleem ning k\u00f5ik ained, mille puhul v\u00f5ib olla sooritust parandav m\u00f5ju, peaksid olema keelatud.<\/p>\n<p>\u201eMa olen dopingule kategooriliselt vastu. Kui teadus ja uuringud kinnitavad, et GLP-1 ravimid on ohtlikud, toetan t\u00e4ielikult nende kasutamise keelustamist ja eluaegset v\u00f5istluskeeldu nende tarvitamise korral,\u201c \u00fctles Bouchard.<\/p>\n<p>GLP-1 ravimite hulka kuuluvad muuhulgas semaglutiid ja tirsepatiid. Williams on avalikult r\u00e4\u00e4kinud nende kasutamisest ning s\u00fcstinud tirsepatiidi endale isegi reklaamvideos.<\/p>\n<p>Williamsi tagasitulek suurde tennisesse pole osutunud kuigi edukaks. \u00dcksikm\u00e4ngus on ta pidanud \u00fche mat\u0161i, kui <a rel=\"noopener nofollow\" target=\"_blank\" href=\"https:\/\/www.delfi.ee\/teema\/48708565\/wimbledon\" tag-id=\"48708565\">Wimbledoni<\/a> avaringis tunnistas ta austraallanna Maya Jointi paremust. Paarism\u00e4ngus on ta parimal juhul j\u00f5udnud teise ringi. Williams osales koos oma \u00f5e Venusega paarism\u00e4ngus ka US Openil, kuid seal piirduti \u00fche kohtumisega.<\/p>\n<p>Kuidas see lugu Sind end tundma pani?Saada<a href=\"https:\/\/sport.delfi.ee\/artikkel\/120609679\/endine-konkurent-suudistab-serena-williamsit-kui-need-ravimid-on-ohtlikud-toetan-eluaegset-voistluskeeldu\/kommentaarid\" class=\"button button--primary button--size-auto article-body-bottom__comment article-body-bottom__comment--write\" style=\"\" rel=\"nofollow noopener\" target=\"_blank\">Kommenteeri<\/a><a href=\"https:\/\/sport.delfi.ee\/artikkel\/120609679\/endine-konkurent-suudistab-serena-williamsit-kui-need-ravimid-on-ohtlikud-toetan-eluaegset-voistluskeeldu\/kommentaarid\" class=\"button button--size-auto article-body-bottom__comment article-body-bottom__comment--read\" style=\"\" rel=\"nofollow noopener\" target=\"_blank\">Loe kommentaare (1)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"32-aastane Bouchard, kes hoidis karj\u00e4\u00e4ri parimal p\u00e4eval maailma edetabelis viiendat kohta, t\u00f5i intervjuus v\u00e4ljaandele Front Office Sports v\u00e4lja,&hellip;\n","protected":false},"author":2,"featured_media":272844,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[14],"tags":[131,130,6009,37,33,35,34,36,9340,28125,2827,3757,6777],"class_list":["post-272843","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ari","tag-ari","tag-business","tag-doping","tag-ee","tag-eesti","tag-eesti-keel","tag-estonia","tag-estonian","tag-eugenie-bouchard","tag-serena-williams","tag-tennis","tag-wada","tag-wimbledon"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ee\/117246095670736155","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/272843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/comments?post=272843"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/272843\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media\/272844"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media?parent=272843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/categories?post=272843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/tags?post=272843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}